Table 3

Costs among HCV patients and controls
HCV Patients Non-HCV Matched controls
(n = 286) (n = 56,880) (n = 286)
Mean SD Mean SD p-value* Mean SD p-value
Indirect costs
 Absenteeism € 2,038.63 € 6,048.12 € 1,357.90 € 5,326.81 <.001 € 1,253.43 € 4,884.92 .011
 Presenteeism € 5,493.91 € 6,898.97 € 3,368.88 € 5,479.10 <.001 € 3,298.06 € 5,454.64 .001
 Total indirect € 7,532.54 € 9,879.57 € 4,729.20 € 7,786.24 <.001 € 4,576.29 € 7,365.19 .002
Direct costs
 Physician visits € 486.61 € 649.61 € 288.54 € 410.89 <.001 € 329.52 € 536.32 <.001
 ER visits € 71.68 € 233.24 € 40.72 € 207.97 .007 € 42.94 € 137.86 .360
 Hospitalizations € 588.77 € 1,867.19 € 288.19 € 2,754.17 <.001 € 279.62 € 991.20 .075
Total direct costs € 1,147.06 € 2,265.46 € 617.45 € 2,889.90 <.001 € 652.07 € 1,373.94 <.001
Total costs € 4,587.54 € 8,653.64 € 3,291.01 € 7,154.33 <.001 € 2,685.28 € 5,530.30 <.001

Comparisons indirect costs include only the employed subsamples: 138 HCV patients, 32,179 non-HCV, and 134 matched controls. Comparisons of direct and total costs include the full samples. Unemployed respondents’ indirect costs are included in total costs as €0.

*Indicates the significance comparing the HCV group with the unmatched control group. †Indicates the significance comparing the HCV group with the matched control group.

Vietri et al.

Vietri et al. BMC Gastroenterology 2013 13:16   doi:10.1186/1471-230X-13-16

Open Data